Concepedia

G Migneco

GM

Statistics

Publications

14

Citations

1.7K

H-Index

12

Active since

1985

Affiliations

University of Leeds(Current)

St James's University Hospital

Thomas Jefferson University

Institute of Cancer Research

Schlumberger (Ireland)

G Migneco is an author at University of Leeds specializing in oncology, medicine, and life sciences.

Publications per year

1985–2022

14

Publications

14

Intravenous delivery of oncolytic reovirus to brain tumor patients immunologically primes for subsequent checkpoint blockade

Adel Samson, Karen J. Scott, David J. Taggart et al. · Science Translational Medicine · 2018 · 377 citations · Full text

Medicine, Immunology, Oncology +17

Tumor cells induce the cancer associated fibroblast phenotype via caveolin-1 degradation: Implications for breast cancer and DCIS therapy with autophagy inhibitors

Ubaldo Martinez‐Outschoorn, Stephanos Pavlides, Diana Whitaker‐Menezes et al. · Cell Cycle · 2010 · 244 citations · Full text

Medicine, Cell Biology, Oncology +17

The autophagic tumor stroma model of cancer

Stephanos Pavlides, Aristotelis Tsirigos, G Migneco et al. · Cell Cycle · 2010 · 231 citations

Life Sciences, Cell Biology, Oncology +17

HIF1-alpha functions as a tumor promoter in cancer-associated fibroblasts, and as a tumor suppressor in breast cancer cells

Barbara Chiavarina, Diana Whitaker‐Menezes, G Migneco et al. · Cell Cycle · 2010 · 229 citations · Full text

Medicine, Cancer Biology, Cell Biology +17

The reverse Warburg Effect: Glycolysis inhibitors prevent the tumor promoting effects of caveolin-1 deficient cancer associated fibroblasts

Gloria Bonuccelli, Diana Whitaker‐Menezes, Remedios Castelló-Cros et al. · Cell Cycle · 2010 · 217 citations · Full text

Medicine, Cancer Biology, Oncology +17

1–5 of 14